學部概況
教師隊伍
人才培養
學院、部
臨床醫院
科學研究
管理服務
交流合作
北醫產業
ENGLISH
 
 
 
 招生就業
 招聘信息
 校園文化
 服務平臺
 信息周刊
 校友會
首頁 >> 學術講座 >>

(5月17日)北京大學基礎醫學院院長論壇
發布日期:2019-05-14 瀏覽次數: 字號:[ ]

  報告題目: The acetylation code of p53 in tumor suppression

  報 告 人: Wei Gu, Ph.D.

  Abraham and Mildred Goldstein Professor

  Vice Chair, Department of Pathology and Cell Biology

  Institute for Cancer Genetics, Columbia University

  時    間: 2019 年 5 月 17 日(星期五)下午 2:30-3:30

  地    點: 醫學部國際合作處會議室

  主 持 人: 羅建沅 教授

  報告人簡介:

  Dr. Wei Gu is recognized internationally for the pioneering contributions to the regulation of p53-mediated tumor suppressor function. The research of his laboratory has also made significant impacts in establishing two major basic concepts in biochemistry. The first one is that reversal acetylation of non-histone proteins is important for controlling its activities. The second concept is that ubiquitination is reversible and that deubiquitination is a critical step for modulating protein stability.

  Representative Publications:

  1. Luo, J, Su, F., Chen, D., Shiloh, A., and Gu, W. (2000) Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 408, 377-381.

  2. Luo, J., Nikolaev, A. Y., Imai, S., Chen, D., Su, F., Shiloh, A., Guarente, L., and Gu, W. (2001) Negative control of p53 by Sir2a promotes cell survival under stress. Cell. 107, 137-148.

  3. Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., and Gu. W. (2002). Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416, 648-653.

  4. Nikolaev, A. Y., Li, M., Puskas, N., Qin, J., and Gu, W. (2003). Parc: a cytoplasmic anchor for p53. Cell 112, 29-40.

  5. Li, M., Brooks, C, Wu-Baer, F., Chen, D., Baer, R., and Gu, W. (2003). Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 302, 1972-5.

  6. Chen, D., Kon, N., Li, M., Zhang, W., Qin, J., and Gu, W. (2005) ARF-BP1 is a critical mediator of the ARF tumor suppressor. Cell. 121,1071-83.

  7. Zhao, W., Kruse, JP, Tang, Y., Jung, S., Qin, J., and Gu, W. (2008) Negative Regulation of the Sirt1 deacetylase by DBC1. Nature 451, 587-590.

  8. Kruse, J.P. and Gu, W. (2008) Snapshot: p53 post-translational modifications. Cell 133, 930.

  9. Tang, Y., Zhao, W., Chen, Y., Zhao, Y., and Gu, W. (2008) Acetylation is indispensible for p53 activation. Cell,133, 612-626.

  10. Kruse JP, Gu W.  (2009) Modes of p53 regulation. Cell. 137, 609-622.

  11. Chen, D., Shan, J., Zhu, W., Qin, J. and Gu, W. (2010) Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses. Nature. 464, 624-627.

  12. Li T., Kon N., Jiang L., Tan M., Ludwig T., Zhao Y., Baer R., and Gu W. (2012) Tumor suppression in the absence of p53-mediated cell cycle arrest, apoptosis, and senescence. Cell, 149, 1269-1283. PMID: 22682249.

  13. Jiang L., Kon N., Li T., Wang S., Su T, Hibshoosh H., Baer R., and Gu W(2015). Ferroptosis as a p53-mediated activity during tumor suppression. Nature. 520, 57-62.

  14. Wang D, Kon N, Lasso G, Jiang L, Leng W, Zhu WG, Qin J, Honig B, Gu W. (2016) Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode. Nature. 6; 538(7623):118-122.

  歡迎師生參加!




电竞选手排行榜前十名 關閉窗口

版權所有:北京大學醫學部 北京市海淀區學院路38號  郵編:100191  京ICP備05065075號-19